166 related articles for article (PubMed ID: 27005406)
1. Pirfenidone-induced severe phototoxic reaction in a patient with idiopathic lung fibrosis.
Papakonstantinou E; Prasse A; Schacht V; Kapp A; Raap U
J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1354-6. PubMed ID: 27005406
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone-induced photosensitivity confirmed by pathological phototest.
Ferrer Guillén B; Giácaman MM; Valenzuela Oñate C; Magdaleno Tapial J; Hernández Bel P; Pérez Ferriols A
Photodiagnosis Photodyn Ther; 2019 Mar; 25():103-105. PubMed ID: 30468899
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Xaubet A; Serrano-Mollar A; Ancochea J
Expert Opin Pharmacother; 2014 Feb; 15(2):275-81. PubMed ID: 24308635
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone. First, do no harm.
Prescrire Int; 2013 May; 22(138):117-9. PubMed ID: 23819168
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of skin photosensitivity induced by pirfenidone.
Wang C; He Y; Sun W; Wu C; Li Z; Sun L
J Clin Pharm Ther; 2022 Feb; 47(2):194-199. PubMed ID: 34655088
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Poletti V; Ravaglia C; Tomassetti S
Expert Rev Respir Med; 2014 Oct; 8(5):539-45. PubMed ID: 25113033
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis.
Selvaggio AS; Noble PW
Annu Rev Med; 2016; 67():487-95. PubMed ID: 26565677
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases.
Oltmanns U; Kahn N; Palmowski K; Träger A; Wenz H; Heussel CP; Schnabel PA; Puderbach M; Wiebel M; Ehlers-Tenenbaum S; Warth A; Herth FJ; Kreuter M
Respiration; 2014; 88(3):199-207. PubMed ID: 25115833
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone: a review of its use in idiopathic pulmonary fibrosis.
Kim ES; Keating GM
Drugs; 2015 Feb; 75(2):219-30. PubMed ID: 25604027
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis].
Bonella F; Wessendorf TE; Costabel U
Dtsch Med Wochenschr; 2013 Mar; 138(11):518-23. PubMed ID: 23423955
[TBL] [Abstract][Full Text] [Related]
12. Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis.
Arai T; Inoue Y; Sasaki Y; Tachibana K; Nakao K; Sugimoto C; Okuma T; Akira M; Kitaichi M; Hayashi S
Respir Investig; 2014 Mar; 52(2):136-43. PubMed ID: 24636270
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice.
Okuda R; Hagiwara E; Baba T; Kitamura H; Kato T; Ogura T
Respir Med; 2013 Sep; 107(9):1431-7. PubMed ID: 23849626
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone in idiopathic pulmonary fibrosis.
Maher TM
Drugs Today (Barc); 2010 Jul; 46(7):473-82. PubMed ID: 20683502
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels.
Koga Y; Hachisu Y; Tsurumaki H; Yatomi M; Kaira K; Ohta S; Ono J; Izuhara K; Dobashi K; Hisada T
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31108995
[No Abstract] [Full Text] [Related]
16. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
17. Pirfenidone: a novel agent for the treatment of idiopathic pulmonary fibrosis.
Potts J; Yogaratnam D
Ann Pharmacother; 2013 Mar; 47(3):361-7. PubMed ID: 23404802
[TBL] [Abstract][Full Text] [Related]
18. A safety evaluation of pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Anderson A; Shifren A; Nathan SD
Expert Opin Drug Saf; 2016 Jul; 15(7):975-82. PubMed ID: 27177012
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan.
Taguchi Y; Ebina M; Hashimoto S; Ogura T; Azuma A; Taniguchi H; Kondoh Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T;
Respir Investig; 2015 Nov; 53(6):279-87. PubMed ID: 26521105
[TBL] [Abstract][Full Text] [Related]
20. A Case of Pirfenidone-Induced Photosensitive Drug Eruption.
Jeong SH; Hong EH; Park EJ; Kim KJ; Kim KH
Ann Dermatol; 2023 May; 35(Suppl 1):S48-S51. PubMed ID: 37853864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
